EUVIMEDEuropean Health Evidence
Uhr Sources10/10 Journal Tree
Easy Demo

European Health Evidence

The European alternative to PubMed

EUVIMED is the European alternative to PubMed: a central, multilingual research platform for medicine, nursing, life sciences and healthcare. It brings together international and European literature sources, study registries, open-access full texts, citations and retraction notices in one search. Unlike pure bibliographic databases, EUVIMED supports the entire research process – from discovery and appraisal with LIVIA and CLARA to traceable evidence synthesis. European in focus, transparent, interoperable and designed for science and healthcare.

EuropeanMultilingualInteroperableTraceable

EUVIMED BETA

EUVIMED is currently in beta

EUVIMED is under continuous development. Features, data coverage and presentation may change or be temporarily incomplete.

Results are beta

Search results, classifications, summaries and AI-assisted assessments may be incomplete, delayed or incorrect.

Check original sources

Do not use EUVIMED results without verification for diagnosis, treatment or other clinical decisions. Always consult the original source and applicable guidelines.

Errors and feedback help us improve EUVIMED: info@euvimed.com

Lokaler Crossref-Datenbestand · journal-article

Deep Business Analytics and Artificial Complementary Intelligence: A Pre-Emptive Control Framework for Human–AI Integration in Digital Health Commodity Networks

Mahdi Seify

Commodities · 2026

Vollständiger Abstract

Worum geht es in dieser Arbeit?

Digital health commodity networks process billions of transactions annually, yet European health systems exhibit diagnostic lags of 30–180 days between anomalous events and institutional detection. Existing governance architectures are retrospective by design, and no existing framework combines pre-emptive predictive control with a principled human–AI cognitive-boundary taxonomy for this setting. This study introduces Deep Business Analytics (DBA), a pre-emptive management control system extending Simons’ four levers of control with a fifth—Predictive Feedforward Control—implemented via Long Short-Term Memory (LSTM) neural networks integrated with a Balanced Scorecard KPI layer. DBA is governed by Artificial Complementary Intelligence (ACI), a four-domain cognitive boundary taxonomy specifying where algorithmic governance is appropriate and where human clinical judgment must retain sovereignty, operationalised within a four-layer Predictive Governance Architecture (PGA). Empirical grounding draws on two deployments: a longitudinal case study at Royal Liverpool Hospital NHS Trust conducted over 28 consecutive days in 2023 (>10 million timestep records; RMSE = 0.00436) and a practitioner case study of 15 million GKV prescriptions processed in 2023 (VisionXY7; approximately 95% anomaly detection accuracy; Governance Velocity Improvement Ratio≈180:1). The ACI boundary taxonomy identifies two governance domains structurally unsuitable for autonomous AI decision-making. DBA and ACI together constitute an integrated, EU AI Act Annex III-compliant architecture that transforms health network AI governance from retrospective detection to pre-emptive control with principled human–AI boundaries.

Bibliografischer Nachweis

Publikationsdaten

Autor:innen
Mahdi Seify
Quelle
Commodities
Publikation
2026-01-01
Band / Ausgabe
Nicht angegeben
Seiten
Nicht angegeben
ISSN / ISBN
2813-2432
Zitationen
0 laut Crossref
Referenzen
0 hinterlegt

Zitieren

Zitierfähiger Nachweis

Mahdi Seify (2026). Deep Business Analytics and Artificial Complementary Intelligence: A Pre-Emptive Control Framework for Human–AI Integration in Digital Health Commodity Networks. Commodities. https://doi.org/10.3390/commodities5030020
RIS BibTeX CSL-JSON

Kontext

Themen, Förderung und Nutzung

Lizenzhinweise: Lizenz 1